rs41339945
Positions:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_ModerateBP6_ModerateBP7BS1BS2
The NM_014339.7(IL17RA):āc.855C>Gā(p.Pro285Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000431 in 1,614,078 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.0022 ( 0 hom., cov: 33)
Exomes š: 0.00024 ( 3 hom. )
Consequence
IL17RA
NM_014339.7 synonymous
NM_014339.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.250
Genes affected
IL17RA (HGNC:5985): (interleukin 17 receptor A) Interleukin 17A (IL17A) is a proinflammatory cytokine secreted by activated T-lymphocytes. It is a potent inducer of the maturation of CD34-positive hematopoietic precursors into neutrophils. The transmembrane protein encoded by this gene (interleukin 17A receptor; IL17RA) is a ubiquitous type I membrane glycoprotein that binds with low affinity to interleukin 17A. Interleukin 17A and its receptor play a pathogenic role in many inflammatory and autoimmune diseases such as rheumatoid arthritis. Like other cytokine receptors, this receptor likely has a multimeric structure. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 22-17104734-C-G is Benign according to our data. Variant chr22-17104734-C-G is described in ClinVar as [Benign]. Clinvar id is 542924.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr22-17104734-C-G is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.25 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00223 (340/152280) while in subpopulation AFR AF= 0.00782 (325/41540). AF 95% confidence interval is 0.00712. There are 0 homozygotes in gnomad4. There are 156 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL17RA | NM_014339.7 | c.855C>G | p.Pro285Pro | synonymous_variant | 9/13 | ENST00000319363.11 | NP_055154.3 | |
IL17RA | NM_001289905.2 | c.855C>G | p.Pro285Pro | synonymous_variant | 9/12 | NP_001276834.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL17RA | ENST00000319363.11 | c.855C>G | p.Pro285Pro | synonymous_variant | 9/13 | 1 | NM_014339.7 | ENSP00000320936.6 | ||
IL17RA | ENST00000612619.2 | c.855C>G | p.Pro285Pro | synonymous_variant | 9/12 | 5 | ENSP00000479970.1 | |||
IL17RA | ENST00000694951.1 | n.813C>G | non_coding_transcript_exon_variant | 7/7 |
Frequencies
GnomAD3 genomes AF: 0.00223 AC: 340AN: 152162Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
340
AN:
152162
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000529 AC: 133AN: 251384Hom.: 0 AF XY: 0.000353 AC XY: 48AN XY: 135882
GnomAD3 exomes
AF:
AC:
133
AN:
251384
Hom.:
AF XY:
AC XY:
48
AN XY:
135882
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000244 AC: 356AN: 1461798Hom.: 3 Cov.: 31 AF XY: 0.000204 AC XY: 148AN XY: 727208
GnomAD4 exome
AF:
AC:
356
AN:
1461798
Hom.:
Cov.:
31
AF XY:
AC XY:
148
AN XY:
727208
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00223 AC: 340AN: 152280Hom.: 0 Cov.: 33 AF XY: 0.00210 AC XY: 156AN XY: 74456
GnomAD4 genome
AF:
AC:
340
AN:
152280
Hom.:
Cov.:
33
AF XY:
AC XY:
156
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Immunodeficiency 51 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at